Understanding the Link Between Circadian Rhythms and Severe Depression
Enhancing the monitoring of sleep and wake hours in patients suffering from severe depression may hold the key to developing personalised therapies for this condition. Recent research conducted by scientists at the University of Sydney suggests that certain clinical depression cases are linked to disruptions in the biological clock, which could exacerbate specific symptoms and lead to resistance to standard medications.
The study aimed to uncover the biological mechanisms that explain the symptomatic differences observed in individuals with clinical depression. While the disorder presents some common characteristics, scientific literature has documented variations among patients. The authors of this new research assert that understanding the processes contributing to these differences could pave the way for more effective treatments.
The Role of Circadian Rhythms in Depression
With this premise in mind, the research focused on determining whether circadian rhythms could influence these variations. This term refers to the biological clock that regulates functions such as sleep, wakefulness, body temperature, hormone release, and changes in alertness. These cycles, lasting approximately 24 hours, synchronise with environmental cues, particularly light.
The findings revealed that, in some individuals, circadian rhythms do not align appropriately with their daily activities or exhibit alterations that may be related to a potential new subtype of depression, referred to as circadian depression.
Defining Circadian Depression
The results do not definitively establish whether depression directly causes disruptions in the biological clock, whether circadian rhythms change as a consequence of the disorder, or if both phenomena are correlated. However, the researchers propose a clinical profile that could aid in understanding one in four cases of major depressive disorder.
This suggested subtype includes six criteria: delayed sleep schedules, a preference for nocturnal activity, discrepancies in rest between workdays and weekends, increased sleep during depressive episodes, feelings of fatigue upon waking, and seasonal changes in sleep duration, social activity, mood, weight, appetite, or energy levels.
According to the study published in the British Journal of Psychiatry, a person must meet at least three of the aforementioned traits to be considered as having circadian depression. Identifying this pattern does not constitute an independent diagnosis nor does it imply that all individuals with these traits will respond similarly to a specific therapeutic intervention.
Research Findings and Statistical Insights
Upon analysing clinical and genetic data from 11,380 Australian adults with severe depression, the scientists determined that approximately 23% fit this profile. Among this group, 80% were women, with an average age of 37.8 years.
The most common combination of characteristics among patients identified with the potential circadian subtype included a preference for nocturnal activity, morning fatigue, and increased sleep during intense depressive episodes. The analysis also indicated that for those whose patterns aligned with circadian depression, the disorder typically began at an average age of 18.7 years, while others reported an average onset age of 23.2 years.
Individuals identified with this proposed subtype were also more likely to experience weight gain during severe depressive episodes and to exhibit more intense symptoms, such as hallucinations and suicidal thoughts.
Genetic Characteristics and Treatment Resistance
Furthermore, the evaluation of genetic characteristics suggested that patients displaying signs of circadian depression might have a higher risk of developing attention deficit hyperactivity disorder (ADHD), major depression, anxiety, bipolar disorder, inflammation, and insulin resistance.
The researchers also assessed the response of this group to standard depression treatments, including selective serotonin reuptake inhibitors (SSRIs). Based on self-reported data, the authors found that members of this subgroup appeared to exhibit greater resistance to these therapies and to experience more severe side effects. However, they acknowledged that these conclusions might be biased, as they stem from patient-reported information rather than clinical trial data.
The Implications of Discovering a New Subtype
Emiliana Tonini, a researcher at the Centre for the Mind at the University of Sydney, stated, “Our research has identified circadian depression as a new subtype affecting around one-quarter of the individuals included in our study on severe, recurrent, or persistent depression.”
As the lead author of the study, Tonini emphasised that these findings provide new evidence regarding the heterogeneity of depression, highlighting that it does not manifest uniformly across all individuals. In her view, this understanding could facilitate the development of more personalised therapies and promote early access to treatment.
Tonini and her colleagues suggest that individuals with circadian depression might benefit from more effective treatments through techniques aimed at regulating the biological clock, such as those based on melatonin or light exposure. However, further studies are necessary to verify this hypothesis.
The authors acknowledge several limitations in their work, including the predominant European ancestry of participants, reliance on self-reported data regarding treatment efficacy and side effects, as well as the possibility that pre-existing severe depression may have caused or exacerbated some of the observed sleep disturbances.
Nevertheless, the researchers conclude that “despite these limitations, this study reinforces the evidence supporting the existence of a circadian subtype of depression as a biologically valid and clinically useful phenotype, associated with differential treatment responses, clinical course characteristics, and a distinct genetic profile.”